Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation

Bone Marrow Transplantation

Volumn 23, Issue 3, 1999, Pages 265-269

  Abbott, B ^a,b   Ippoliti, C ^a   Bruton, J ^a   Neumann, J ^a   Whaley, R ^a   Champlin, R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Ortho Biotech Oncology   (United States)

Author keywords

Antiemetic; Bone marrow transplantation; Emesis; Granisetron; Total body irradiation; Vomiting

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; GRANISETRON;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LYMPHOMA; MALE; NAUSEA; PRIORITY JOURNAL; VOMITING; WHOLE BODY RADIATION;

EID: 0033065057     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701565     Document Type: Article

References (22)

1. Wiebe VJ, Smith BR, Degregorio MW et al. Pharmacology of agents used in bone marrow transplant conditioning regimens. Crit Rev Oncol Hematol 1992; 13: 241-270.
2. Griffin AM, Butow PN, Coates AS et al. On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 1996; 7: 189-195.
3. Del Favero A, Roila F, Tonato M. Reducing chemotherapy-induced nausea and vomiting: current perspectives and future possibilities. Drug Saf 1993; 9: 410-428.
4. Gralla RJ. Antiemetic treatment for cancer chemotherapy: problems and progress. Support Care Cancer 1994; 2: 275-276.
5. 3-receptor antagonists. Support Care Cancer 1994; 2: 286-292.
6. Prentice HG, Cunningham S, Gandhi L et al. Granisetron in the prevention of irradiation-induced emesis. Bone Marrow Transplant 1995; 15: 445-448.
7. Roberts JT, Priestman TJ. A review of ondansetron in the management of radiotherapy-induced emesis. Oncology 1993; 50: 173-179.
8. Agura ED, Brown MC, Schaffer R et al. Antiemetic efficacy and pharmacokinetics of intravenous ondansetron infusion during chemotherapy conditioning for bone marrow transplant. Bone Marrow Transplant 1995; 16: 213-222.
9. Belkacémi Y, Ozsahin M, Pène F et al. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis. Int J Radiat Oncol Biol Phys 1996; 36: 77-82.
10. Dagher R, Robertson KA, Lucas KG et al. Outpatient total body irradiation for pediatric patients undergoing stem cell transplantation. Bone Marrow Transplant 1997; 19: 1065-1067.
11. Fauser AA, Russ W, Bischoff M. Oral dolasetron mesilate (MDL 73, 147EF) for the control of emesis during fractionated total-body irradiation and high-dose cyclophosphamide in patients undergoing allogeneic bone marrow transplantation. Support Care Cancer 1997; 5: 219-222.
12. Spitzer TR, Bryson JC, Cirenza E et al. Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation. J Clin Oncol 1994; 12: 2432-2438.
13. Alfieri AB, Cubeddu LX. Treatment with para-chlorophenylalanine antagonizes the emetic response and the serotonin-releasing actions of cisplatin in cancer patients. Br J Cancer 1995; 71: 629-632.
14. Miner WD, Sanger GJ, Turner DH. Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis. Br J Cancer 1987; 56: 159-162.
15. Sanger GJ. The pharmacology of anti-emetic agents. In: Andrews PLR, Sanger GJ (eds). Emesis in Anti-cancer Therapy: Mechanisms and Treatment. Chapman & Hall Medical: London, 1993, pp 179-210.
16. Andrews PLR. The pharmacologic profile of granisetron (Kytril). Semin Oncol 1994; 21 (Suppl. 5): 3-9.
17. Perez EA, Gandara DR. The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis. Semin Oncol 1994; 21 (Suppl. 5): 15-21.
18. Yarker YE, McTavish D. Granisetron: an update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy. Drugs 1994; 48: 761-793.
19. 3-receptor antagonists in emetogenic chemotherapy regimens. Formulary 1996; 31: 1071-1080.
20. 3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation. Bone Marrow Transplant 1991; 7: 439-441.
21. Okamoto S, Takahashi S, Tanosaki R et al. Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study. Bone Marrow Transplant 1996; 17: 679-683.
22. Lawrence CC, Gilbert CJ, Peters WP. Evaluation of symptom distress in a bone marrow transplant outpatient environment. Ann Pharmacother 1996; 30: 941-945.